Background Information: Botulinum Toxin-A (BoNT/A) is being used as an adjunct to therapy to reduce focal spasticity, increase range of motion (ROM), manage pain, improve function, and possibly delay surgical intervention (Hoare & Imms, 2004). BoNT/A inhibits acetylcholine release at the neuromuscular junction resulting in temporary denervation and decreased muscular activity. Reinnervation eventually restores muscle function. Adverse effects include excessive weakness and atrophy of injected muscle, unintended weakness in adjacent muscles, and immunoresistance to BoNT/A (Ghasemi, Salari, Khorvash, & Shaygannejad, 2013)
Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and sh...
Michelle Kaku, David M Simpson Department of Neurology, Icahn School of Medicine at Mount Sinai, Ne...
Botulinum toxin type A (BoNT-A) acts peripherally by inhibiting acetylcholine release from the presy...
Background Information: Botulinum Toxin-A (BoNT/A) is being used as an adjunct to therapy to reduce ...
Botulinum toxin type-A (BoNT-A) prevents the release of acetylcholine at cholinergic junctions, ther...
Background and Purpose Botulinum toxin type A (BoNT/A) injections into hyperactive muscles provide e...
Objective: The adverse events (AEs) with botulinum toxin type-A (BoNTA), used for indications other ...
Botulinum toxin (BoNT) injections into facial and bulbar muscles are widely and increasingly used as...
Botulinum neurotoxin (BoNT) is most commonly used to reduce focal over-activity in skeletal muscle, ...
Spasticity with muscle paresis and loss of dexterity is a common feature of upper motor neuron syndr...
Botulinum toxin (BoNT) injections into facial and bulbar muscles are widely and increasingly used as...
Background. Botulinum toxin A (BoNT-A) injections are increasingly used to treat muscle spasticity a...
Spasticity is a muscle tone disorder associated with different neurological conditions. Spasticity c...
The use of intramuscular injections of Botulinum neurotoxin A (BoNT-A) is common in the treatment of...
Abstract Background Treatment for patients with chronic low-back pain (LBP) is a public health issue...
Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and sh...
Michelle Kaku, David M Simpson Department of Neurology, Icahn School of Medicine at Mount Sinai, Ne...
Botulinum toxin type A (BoNT-A) acts peripherally by inhibiting acetylcholine release from the presy...
Background Information: Botulinum Toxin-A (BoNT/A) is being used as an adjunct to therapy to reduce ...
Botulinum toxin type-A (BoNT-A) prevents the release of acetylcholine at cholinergic junctions, ther...
Background and Purpose Botulinum toxin type A (BoNT/A) injections into hyperactive muscles provide e...
Objective: The adverse events (AEs) with botulinum toxin type-A (BoNTA), used for indications other ...
Botulinum toxin (BoNT) injections into facial and bulbar muscles are widely and increasingly used as...
Botulinum neurotoxin (BoNT) is most commonly used to reduce focal over-activity in skeletal muscle, ...
Spasticity with muscle paresis and loss of dexterity is a common feature of upper motor neuron syndr...
Botulinum toxin (BoNT) injections into facial and bulbar muscles are widely and increasingly used as...
Background. Botulinum toxin A (BoNT-A) injections are increasingly used to treat muscle spasticity a...
Spasticity is a muscle tone disorder associated with different neurological conditions. Spasticity c...
The use of intramuscular injections of Botulinum neurotoxin A (BoNT-A) is common in the treatment of...
Abstract Background Treatment for patients with chronic low-back pain (LBP) is a public health issue...
Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and sh...
Michelle Kaku, David M Simpson Department of Neurology, Icahn School of Medicine at Mount Sinai, Ne...
Botulinum toxin type A (BoNT-A) acts peripherally by inhibiting acetylcholine release from the presy...